StreetAlpha.app
Home › Stocks › BRTX

BioRestorative Therapies, Inc. (BRTX)

$1.34
▼ −2.19%
LAST CLOSE · NOV 17

BioRestorative Therapies develops adult stem cell treatments for spine and metabolic conditions and sells a cosmetic skin serum. It last closed at $1.34 on Nov 17, down 2.19% on the day. BRTX reports earnings on Wed, Nov 18, 2026.

AI Auto Pilots
Is BRTX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$358K
−8.5% vs a year ago
Net income
−$11.1M
−3089.6% margin
EPS (diluted)
−$1.06
Gross margin
92.1%
$330K gross profit
Valuation
Market cap
$34.1M
25.5M shares
P/E
–
No P/E while losing money
Price to sales
95.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$3.1M
At Mar 31
Shareholder equity
$3.0M
Shares outstanding
25.5M
At May 14
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $46K$46KFY2021FY2022: $120K$120KFY2022FY2023: $146K$146KFY2023FY2024: $401K$401KFY2024FY2025: $360K$360KFY2025

From BRTX's SEC filings, latest 10-Q for the period ending Mar 31, 2026 (filed May 14). Last 12 months adds up the four latest quarters.

Next report
Nov 18
2026 · Time not announced
Consensus EPS forecast
-$1.40
$650,000 revenue est.
Year-ago EPS
-$0.33
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
—
No ratings in 90 days
Loading…

Technical Analysis

BRTX · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold

The stock is 11% below its 20 day and 45% below its 50 day average. It is 274% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 32), near oversold. The nearest support is the Pivot S1 at $1.32, and the nearest resistance the Pivot at $1.36.

Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 10.7%/day
Key levels
$29.0052 week high+2064.2%
$5.02200 day average+274.6%
$3.59100 day average+167.9%
$1.9450 day average+44.8%
$1.64Swing high (Nov 12)+22.4%
$1.4920 day average+11.2%
$1.37Pivot R1+2.2%
$1.36Pivot+1.5%
$1.34Last close
$1.32Pivot S1−1.5%
$1.2852 week low−4.5%
$1.28Swing low (Oct 15)−4.5%
Indicators
RSI (14)32.39Weak, oversold below 30Neutral
MACD-0.16Above its signal lineBullish
Stochastic11.6Near the bottom of its rangeOversold
ADX (14)31.5Trending down
Williams %R-99.8Oversold below −80, overbought above −20Oversold
CCI (20)-203.3Oversold below −100, overbought above 100Oversold
Rate of change−9.5%Change over 10 sessionsBearish
ATR (14)$0.14Typical daily range, 10.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for BRTX

What happened before

See how BRTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Earnings in less than a daySignals right before a report are less reliable. The report can override them.
November seasonalityHow BRTX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How BRTX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2012.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in BRTX in the last 90 days.

Loading…

See today’s whale options flow across the market →

BRTX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼14 buying vs 21 selling
  • ▼Held by funds -10.1 pts
  • ▼Funds holding -7
  • ▼Superinvestors: 0 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1421−33.3%
In funds' top 1000–
Held by funds0.3%10.5%−10.1 pts
New / increased14 / 010 / 3+7.7%
Reduced / sold out0 / 212 / 0+950.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BRTX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BRTX is in one of them and how their past BRTX trades turned out.

BRTX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BRTX in an article yet. Here's the latest on the wider market.

About BioRestorative Therapies

BioRestorative Therapies develops therapeutic products that use cell and tissue methods, mainly adult stem cells. Its lead candidate is made from a patient's own bone marrow stem cells and is being studied for chronic lower back pain caused by degenerative disc disease and for neck pain, with the aim of offering an option for patients who may otherwise face surgery. The company is also developing metabolic treatments based on stem cells derived from fat, aimed at conditions such as obesity and type 2 diabetes. It sells a skin serum to consumers for fine lines and wrinkles and is based in Melville, New York.

Headquarters
Melville, NY